OAKLAND, Calif., May 21 /PRNewswire/ -- LUMEDX Corporation, a leading provider of fully integrated cardiovascular imaging and information systems (CVIS), introduces software to manage data and track patients on long-term Coumadin (warfarin) therapy. The Anticoagulation Module empowers clinicians by making critical clinical information accessible immediately, improving patient care and safety.
For more information -- including a free Anticoagulation Management Information Kit complete with CD presentation -- visit http://www.lumedx.com/cardiovascular/point-of-care_solutions/anticoagulatio n
The Anticoagulation Module is a part of LUMEDX's suite of integrated
cardiovascular imaging and information management tools, delivering a
robust and unified Cardiovascular Information Systems solution.
The Anticoagulation Module:
-- Increases efficiency by automating the workflow to track lab values,
dosages, complications and more
-- Makes records immediately accessible, on- or off-site
-- Helps satisfy new JCAHO patient safety goals for anticoagulation
-- Promotes quality of data by eliminating hard-to-read handwritten
records and redundant data entry
According to LUMEDX Director of Product Management Rhonda Staton, "The management of patients taking Coumadin requires access to -- and input of -- patient information by multiple people in multiple locations. The Anticoagulation Module streamlines this workflow dramatically and ensures up-to-date, safe and efficient patient care."
To request a free Anticoagulation Management Information Kit, visit http://www.lumedx.com/cardiovascular/point-of-care_solutions/anticoagulatio n
ABOUT LUMEDX CARDIOVASCULAR IMAGING AND INFORMATION SOLUTIONS
(http://www.lumedx.com) With over 500 heart center clients worldwide, LUMEDX is the market leader in fully integrated cardiovascular information systems and the No. 1 independent integrator of cardiology information solutions. Our cardiovascular imaging and information solutions play a critical role in helping healthcare systems meet many of today's challenges and opportunities, including pay-for-performance, evidence-based medicine, greater competition and transparency in the marketplace, and new governmental regulations.
|SOURCE LUMEDX Corporation|
Copyright©2008 PR Newswire.
All rights reserved